AXIM Biotech Announces the Production of CanChew Plus™, the Next Generation Controlled Release CBD Chewing …

NEW YORK, March 01, 2017 (GLOBE NEWSWIRE) — AXIM Biotechnologies, Inc. (AXIM Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, began production of CanChew Plus™, the next generation of the company’s award-winning controlled-release cannabidiol (CBD) functional chewing gum.

CanChew® is the world’s first patented controlled-release cannabinoid chewing gum containing 50 mg of hemp oil and 10 mg of CBD.

CanChew Plus™ contains the same active ingredients and is designed to be 60% smaller than the original CanChew® gums for an improved chewing experience. Most importantly, CanChew Plus™ features a new and improved oral mucosal delivery system through microencapsulation that increases the bioavailability of the active ingredient from less than 50% after chewing for two hours with the prior version of the gum to 80% absorption rate of CBD in just 30 minutes of chewing.

In its natural form, cannabinoids are lipophilic, not water-soluble and tend to stick

... read more at: